# Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer

> **NCT01073683** · PHASE2 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Larynx Cancer

## Interventions

- **PROCEDURE:** laryngoscopy
- **DRUG:** Taxotere (Docetaxel), Cisplatin, 5FU

## Key facts

- **NCT ID:** NCT01073683
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2012-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01073683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01073683, "Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01073683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*